FDA Seeks Schedule I Status for ‘Legal Morphine’
The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…
Back ache? Arthritis? Studies hint that bees could take the sting out of chronic pain
Bees are beloved as pollinators and dreaded for their painful stings. But their venom is also hailed by…
Chronic pain sufferers find relief through UK-first
People living with chronic pain are being offered a pioneering new treatment involving virtual reality headsets, in what…
Frequent gabapentin use linked to higher dementia and cognitive impairment risk
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased…
Guideline Outlines How to Taper Benzodiazepines Safely
Long-term, regular use of benzodiazepines is common and can lead to physical dependence and withdrawal when the dose…
Gabapentin Market Size to Hit USD 3.55 Billion by 2032, Driven by Rising Cases of Epilepsy, Neuropathic Pain, and Off-Label Use – SNS Insider
SNS Insider pvt ltd U.S. Gabapentin Market Growth is Fueled by High Chronic Pain Prevalence and Broad Generic…
Clinicians Push FDA on NarxCare
This article is the second in a series on prescription drug monitoring programs and analysis tools designed to…